Getagraph.com logo
NASDAQ Composite: ( -0.01%) 16 735
S&P 500 Futures
(0.24%) 5 308.25 points
Dow Jones Futures
(0.24%) 38 884 points
Nasdaq Futures
(0.34%) 18 655 points
Oil
(-0.31%) $76.75
Gas
(4.10%) $2.69
Gold
(-0.38%) $2 336.80
Silver
(-0.95%) $30.15
Platinum
(-0.28%) $1 039.10
USD/EUR
(0.02%) $0.922
USD/NOK
(0.11%) $10.50
USD/GBP
(0.00%) $0.785
USD/RUB
(-0.38%) $90.09

Realtime updates for Herantis Pharma Oyj [HRTIS.HE]

Exchange: HEL Sector: Healthcare Industry: Biotechnology
Last Updated31 May 2024 @ 11:19
25% discount on Stockinvest.us - Use code: Podcast

9.12% € 1.855

Live Chart Being Loaded With Signals

Commentary (31 May 2024 @ 11:19):

Herantis Pharma Oyj, a biotech company, engages in the development of disease-modifying CDNF-based therapies for Parkinson's disease (PD). Its lead product in pipeline includes HER-096, an advanced small and synthetic chemical peptidomimetic version of the active parent as the preclinical xCDNF candidate for the treatment of PD and other neurodegenerative diseases; and recombinant human Cerebral Dopamine Neurotrophic Factor (rhCDNF), a biological protein that is in Phase I study in patients with PD...

Stats
Today's Volume 14 435.00
Average Volume 16 974.00
Market Cap 37.40M
EPS €0 ( 2024-03-06 )
Next earnings date ( €0 ) 2024-08-21
Last Dividend €0 ( N/A )
Next Dividend €0 ( N/A )
P/E 92.75
ATR14 €0.0130 (0.70%)

Herantis Pharma Oyj Correlation

10 Most Positive Correlations
10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Herantis Pharma Oyj Financials

Annual 2023
Revenue: €0
Gross Profit: €0 (0.00 %)
EPS: €0.0163
FY 2023
Revenue: €0
Gross Profit: €0 (0.00 %)
EPS: €0.0163
FY 2022
Revenue: €0
Gross Profit: €0 (0.00 %)
EPS: €-0.730
FY 2021
Revenue: €0.00
Gross Profit: €0.00 (0.00 %)
EPS: €-1.250

Financial Reports:

No articles found.

Herantis Pharma Oyj Options Data

Calls

Contract Name Last Trade Date (EDT) Strike Last Price Bid Ask Change % Change Volume Open Interest Implied Volatility Strike Date
No data available

Puts

Contract Name Last Trade Date (EDT) Strike Last Price Bid Ask Change % Change Volume Open Interest Implied Volatility Strike Date
No data available

Herantis Pharma Oyj

Herantis Pharma Oyj, a biotech company, engages in the development of disease-modifying CDNF-based therapies for Parkinson's disease (PD). Its lead product in pipeline includes HER-096, an advanced small and synthetic chemical peptidomimetic version of the active parent as the preclinical xCDNF candidate for the treatment of PD and other neurodegenerative diseases; and recombinant human Cerebral Dopamine Neurotrophic Factor (rhCDNF), a biological protein that is in Phase I study in patients with PD. The company was incorporated in 2008 and is based in Espoo, Finland.

About Live Signals

The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.

The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators

Total Execution Time: 0.76201295852661 seconds
Number of API calls: 2
Number of DB calls: 8